If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
225.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (2.273%)
Market Cap: £109.02m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Result of AGM

25 Mar 2020 13:10

RNS Number : 5812H
Quartix Holdings PLC
25 March 2020
 

Quartix Holdings plc

 

("Quartix" or the "Company")

 

Result of Annual General Meeting

 

 

Quartix Holdings plc, a leading supplier of vehicle telematics services to the fleet and insurance sectors, announces that, at the Annual General Meeting of the Company held yesterday at the Company's registered office at 9 Dukes Court, 54-62 Newmarket Road, Cambridge CB5 8DZ and using conferencing facilities, all the proposed resolutions, with the exception of resolution 2, were passed on confirmation from the participants. Resolution 2, which the Board recommended be rejected, was rejected.

 

The number of proxy votes lodged in advance of the meeting for each of the resolutions are as noted in the table below:

 

Proxy voting table

 

Total issued shares at the date of meeting: 47,938,320

 

Resolution

For

Against

Discretionary

Withheld

Total votes cast

1. To receive and adopt the audited annual accounts for the year ended 31 December 2019.

29,989,692

5,578,267

0

0

35,567,959

2. To approve and declare a final dividend for the year ended 31 December 2019 of 4.2p per ordinary share and supplementary dividend of 5.8p per ordinary share, a total final dividend of 10.0p per share.

10,716,803

28,861,0090

0

0

39,577,812

3. To re-elect Andrew Walters as a Director of the Company.

35,567,959

0

0

0

35,567,959

4. To re-elect Daniel Mendis as a Director of the Company.

35,567,959

0

0

0

35,567,959

5. To re-elect Laura Seffino as a Director of the Company.

35,567,959

0

0

0

35,567,959

6. To re-elect Paul Boughton as a Director of the Company.

35,567,959

0

0

0

35,567,959

7. To re-elect Jim Warwick as a Director of the Company.

35,567,959

0

0

0

35,567,959

8. To re-appoint Grant Thornton UK LLP as the auditors of the Company until the end of the next Annual General Meeting.

35,567,677

282

0

0

35,567,959

9. To authorise the Directors to determine the remuneration of the auditors.

35,567,677

282

0

0

35,567,959

10. To authorise the Directors to allot shares

35,567,959

0

0

0

35,567,959

11.** To authorise the Directors to disapply pre-emptive rights.

35,567,353

606

0

0

35,567,959

12.** To authorise the Company to purchase its own shares.

35,567,959

0

0

0

35,567,959

 

** Special Resolution

 

The full text of the resolutions may be found in the notice of the Annual General Meeting which is available on the Company's website www.quartix.net/company/investors/.

 

 

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Chief Executive Officer

Daniel Mandis, Chief Financial Officer

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode /Scott Mathieson (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSEUFDIESSESD
Date   Source Headline
8th Jul 20267:00 amRNSTrading Statement
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.